Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48
Related Experiment Video
Updated: Feb 9, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Georgia Velimezi1, Lydia Robinson-Garcia1, Francisco Muñoz-Martínez2
1CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, AKH BT 25.3, 1090, Vienna, Austria.
Abstract:
Defects in DNA repair can cause various genetic diseases with severe pathological phenotypes. Fanconi anemia (FA) is a rare disease characterized by bone marrow failure, developmental abnormalities, and increased cancer risk that is caused by defective repair of DNA interstrand crosslinks (ICLs). Here, we identify the deubiquitylating enzyme USP48 as synthetic viable for FA-gene deficiencies by performing genome-wide loss-of-function screens across a panel of human haploid isogenic FA-defective cells (FANCA, FANCC, FANCG, FANCI, FANCD2). Thus, as compared to FA-defective cells alone, FA-deficient cells additionally lacking USP48 are less sensitive to genotoxic stress induced by ICL agents and display enhanced, BRCA1-dependent, clearance of DNA damage. Consequently, USP48 inactivation reduces chromosomal instability of FA-defective cells. Our results highlight a role for USP48 in controlling DNA repair and suggest it as a potential target that could be therapeutically exploited for FA.
Insights
Researchers found that disabling USP48 helps cells with Fanconi anemia (FA) repair DNA damage more effectively. This discovery offers a potential new therapeutic strategy for FA, a genetic disease impacting bone marrow and increasing cancer risk.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Defective DNA repair leads to genetic diseases with severe phenotypes.
- Fanconi anemia (FA) is a rare genetic disorder caused by faulty DNA interstrand crosslink (ICL) repair, resulting in bone marrow failure, developmental issues, and cancer predisposition.
Purpose of the Study:
- To identify genetic modifiers that confer resistance to genotoxic stress in FA-defective cells.
- To investigate the role of USP48 in DNA repair pathways relevant to Fanconi anemia.
Main Methods:
- Genome-wide loss-of-function screens were performed on human haploid isogenic FA-defective cell lines (FANCA, FANCC, FANCG, FANCI, FANCD2).
- Sensitivity to ICL agents and DNA damage clearance were assessed in FA-deficient cells with and without USP48.
- Chromosomal instability was evaluated in FA-defective cells with USP48 inactivation.
Main Results:
- USP48 was identified as a synthetic viable gene for FA-gene deficiencies.
- FA-deficient cells lacking USP48 showed reduced sensitivity to ICL agents and enhanced BRCA1-dependent DNA damage clearance.
- Inactivation of USP48 led to decreased chromosomal instability in FA-defective cells.
Conclusions:
- USP48 plays a role in regulating DNA repair mechanisms.
- USP48 inactivation represents a potential therapeutic target for Fanconi anemia, improving cellular resistance to genotoxic stress.
Related Concept Videos
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mismatch Repair
Base Excision Repair
The first step of...
Base-pairing and DNA Repair

